With so many holes in the DOJ’s complaint, I think it is only fair to reserve judgment until the trial, if there is one. With regard to the Covid 19 allegations, they have it all wrong. Think about it. We all know he said they were working on a test to submit to the FDA for hopeful EUA status. There was no PR to pump things up and no massive undertaking to move the share price and NO claim by the company that their test was FDA authorized. . How silly to say, “The stock price doubled” and leaving out the actual share prices in the complaint. They make it sound like it went from $10.00 to $20.00 when in fact they’re talking about $.01 to $.02 or so. And the company was acting under FDA guidelines, contrary to what is alleged in the complaint. And as you know there are so many other false statements, like how they diluted by “several billion shares.”
Maybe Mark is a nut. I just find it almost impossible to believe he would deliberately throw everything away when the company was experiencing what seemed to be a new beginning of growth and brand new sources of revenue, and then in addition to that, an opportunity to participate in playing an important role in helping to destroy the coronavirus. I still can find no evidence that ARYC’s test has been rejected by the FDA and/or that they have been issued any warning letter or cease and desist orders, and Arrayit is not on any of the FDA’s do-not-use lists.
News 
Market Data 
Discover 
